StockData
BIONYSELaboratory Analytical InstrumentsFiscal year ends December 31Also trades as BIO.B

BIO-RAD LABORATORIES, INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026
$352.82−0.88 (-0.25%)

Close on Oct 19, 2026

Market cap
$9.46B
P/E (TTM)
42.8
Dividend yield
–

BIO-RAD LABORATORIES, INC. revenue by segment

By business segment

RevenueQ2 26Q1 26Q4 25Q3 25Q2 25Q1 25Q4 24Q3 24Q2 24Q1 24Q4 23Q3 23% of revenueYoY
Clinical Diagnostics$399.00M$363.60M$425.30M$391.20M$388.80M$356.80M$392.50M$388.80M$388.00M$368.60M$389.00M$368.10M61.3%+2.6%
Life Science$252.00M$228.50M$267.90M$261.80M$262.80M$228.60M$275.00M$260.90M$250.50M$241.70M$291.10M$263.50M38.7%-4.1%
All Other Segments [Member]––$0$0$0$0$0$0$0$500.00K$1.00M$500.00K––

By product or service

By region

RevenueQ2 26Q1 26Q4 25Q3 25Q2 25Q1 25Q4 24Q3 24Q2 24Q1 24Q4 23Q3 23% of revenueYoY
United States$255.50M$229.80M$244.10M$270.00M$266.90M$241.70M$258.10M$276.20M$254.20M$252.90M$263.10M$275.40M39.2%-4.3%
Europe [Member]$229.20M$206.80M$242.60M$222.20M$217.20M$199.80M$221.70M$205.70M$206.50M$200.20M$210.70M$193.10M35.2%+5.5%
Asia Pacific [Member]$121.80M$110.40M$161.80M$121.00M$126.40M$104.10M$146.40M$126.90M$131.20M$117.20M$164.10M$118.90M18.7%-3.6%
Americas [Member]$44.50M$45.10M$44.70M$39.80M$41.10M$39.80M$41.30M$40.90M$46.60M$40.50M$43.20M$44.70M6.8%+8.3%

From the segment and revenue-disaggregation notes of Bio-Rad Laboratories's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.